T

TherapeuticsMD
D

TXMD

1.30000
USD
0.33
(34.08%)
مغلق
حجم التداول
287,777
الربح لكل سهم
0
العائد الربحي
-
P/E
-3
حجم السوق
14,992,162
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AZN
    AZN
    -0.350
    (-0.47%)
    74.220 USD
    JNJ
    JNJ
    2.680
    (1.68%)
    162.370 USD
    MRK
    MRK
    1.820
    (2.08%)
    89.500 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    P
    PRGO
    0.090
    (0.36%)
    25.340 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    المزيد
الأخبار
المقالات

العنوان: TherapeuticsMD

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.